By Nigam Arora & Dr. Natasha Arora
The Monumental Bill
The top Senate Democrats led by Senator Schumer are introducing a new marijuana bill with great fanfare.
Schumer said, “This is monumental because at long last we are taking stops in the Senate to right the wrongs of the failed war on drugs.”
Here are the key points of the bill:
- The bill would allow states to write their own marijuana laws.
- Marijuana would not be on the federal list of controlled substances.
- The jurisdiction will be taken away from the Drug Enforcement Agency (DEA).
- The record of non-violent marijuana crimes would be expunged.
- SBA will be able to give loans to marijuana businesses.
- The bill will protect banks and allow them to serve marijuana businesses.
Marijuana Model Portfolio
The Arora Marijuana Model Portfolio consists of 11 stocks. These 11 stocks are the top stocks that investors should consider.
Here is the list.
ARNA
CGC
CRLBF
CRON
CURLF
GRWG
GTBIF
GWPH
HYFM
NBEV
TLRY
Only Two Are Buys Now
Our of these 11 stocks, only two are buys now. The others will become a buy when they dip into the buy zones. The Arora Model Portfolio gives you Buy Now Ratings, buy zones, target zones, and recommended position sizes for each of the 11 marijuana stocks.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
